← Leaderboards
Rocco George Gogliotti
Vanderbilt University
$3,490,212
Attributed
$3,490,212
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $774.4K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,490,212 · 4
By mechanism
R01$1,749,276 · 1
R61$774,361 · 1
K01$543,075 · 1
R21$423,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Sarika U Peters$2,112,916
- Nicole Marie Fisher$87,630
- Sheryl Anne Daguimol Vermudez$90,696
- Bridget E Collins$128,597
- Branden J Stansley$112,760
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseAdverse EffectsRett SyndromeProteinsOutcome MeasureMutationPhenotypeResponseMethyl-Cpg-Binding Protein 2BrainMouse ModelGenesNeurodevelopmental DisorderSymptomsMediatingNeuronsSignal TransductionMotor CortexLinkAgonistPharmacologyGeneticMolecularChemosensitization
Grant awards (13)
Preclinical development of novel site blocking ASOs for the treatment of Rett syndrome$774,361
R61 · FY2025 · NS · contact PI
A precision medicine approach to Rett Syndrome$338,285
R01 · FY2024 · NS · contact PI
miRNA site-blocking ASOs as MeCP2 targeted therapeutics$192,500
R21 · FY2024 · HD · contact PI
A precision medicine approach to Rett Syndrome$350,120
R01 · FY2023 · NS · contact PI
miRNA site-blocking ASOs as MeCP2 targeted therapeutics$231,000
R21 · FY2023 · HD · contact PI
A precision medicine approach to Rett Syndrome$353,060
R01 · FY2022 · NS · contact PI
A precision medicine approach to Rett Syndrome$346,929
R01 · FY2021 · NS · contact PI
A precision medicine approach to Rett Syndrome$360,882
R01 · FY2020 · NS · contact PI
Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes$135,084
K01 · FY2020 · MH · contact PI
Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes$82,260
K01 · FY2019 · MH · contact PI
Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes$53,290
K01 · FY2019 · MH · contact PI
Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes$136,001
K01 · FY2018 · MH · contact PI
Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes$136,440
K01 · FY2017 · MH · contact PI